We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Bybit, a leading centralized cryptocurrency exchange (CEX), has released a new report that reveals that most major ...

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...

A Regional Analysis Based on Tourism, E-Commerce, and Education Sectors This study assesses the impact of China’s Value-Added Tax (VAT) and Individual Income Tax (IIT) reforms on per capita income ...